Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer

Zheng Fu, Yasuhide Kitagawa, Ronglai Shen, Rajal Shah, Rohit Mehra, Daniel Rhodes, Peter J. Keller, Atsushi Mizokami, Rodney Dunn, Arul M. Chinnaiyan, Zhi Yao, Evan T. Keller

Research output: Contribution to journalArticle

173 Scopus citations

Abstract

BACKGROUND. Diminished expression of Raf kinase inhibitor protein (RKIP), an inhibitor of the Raf signaling cascade, promotes prostate cancer (PCa) metastasis in a murine model, suggesting that it is a metastasis suppressor gene. However, the prognostic significance of RKIP expression and its association with metastasis in PCa patients is unknown. METHODS. To investigate RKIP protein expression is a prognostic marker in PCa we performed immunohistochemical staining for RKIP expression in tissue microarrays consisting of 758 non-neoplastic prostate tissues, primary tumors and metastases from 134 PCa patients. The Cox proportional-hazards model was used to adjust for covariates including Gleason score, tumor volume, tumor weight, clinical stage, digital rectal exam findings, serum PSA level and surgical margins. RESULTS. RKIP expression was low in approximately 5%, 48%, and 89% of non-neoplastic prostate, primary tumors and metastases, respectively. Low RKIP expression in primary tumors was a strong positive predictive factor for PCa recurrence based on PSA levels. In patients whose primary tumors expressed high RKIP levels, the 7-year PSA recurrence rate was <10%; whereas in patients with tumors with low RKIP expression the recurrence rate was 50% (P < 0.001). Multivariate analysis revealed RKIP was an independent prognostic factor (P < 0.001). CONCLUSION. In contrast to increased expression of pro-tumorigenic genes, these results demonstrate decreased protein expression of a gene, for example, RKIP, can serve as a prognostic marker in PCa patients.

Original languageEnglish (US)
Pages (from-to)248-256
Number of pages9
JournalProstate
Volume66
Issue number3
DOIs
StatePublished - Feb 15 2006
Externally publishedYes

Keywords

  • Metastasis suppressor gene
  • Prognostic marker
  • Prostate cancer
  • RKIP
  • Tissue microarray

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint Dive into the research topics of 'Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer'. Together they form a unique fingerprint.

  • Cite this

    Fu, Z., Kitagawa, Y., Shen, R., Shah, R., Mehra, R., Rhodes, D., Keller, P. J., Mizokami, A., Dunn, R., Chinnaiyan, A. M., Yao, Z., & Keller, E. T. (2006). Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate, 66(3), 248-256. https://doi.org/10.1002/pros.20319